|
|
|
|
Document Preview Investors' Rights Agreement [Amended and Restated No. 2] |
||||
|
|
||||
|
Click "Add to Cart" button to purchase document. |
||||
|
|
||||
|
Title: |
Investors' Rights Agreement [Amended and Restated No. 2] |
|||
|
Entities: |
H&Q Healthcare Investors; H&Q Life Sciences Investors; Novartis Pharma AG; Vicuron Pharmaceuticals, Inc. |
|||
|
Date: |
2000 |
|||
|
Size: |
Preview shows 10KB of 118KB total |
|||
|
Price: |
$51 |
|||
|
ID: |
#331066 |
|||
|
|
||||
|
||||
|
|
||||
|
Start of Preview |
||||
THIS SECOND AMENDED AND RESTATED INVESTORS' RIGHTS AGREEMENT (the
"Agreement") is entered into as of the 29th day of October 1999, by and among
VERSICOR INC., a Delaware corporation (the "Company"), the holders of the
Company's Series A Preferred Stock ("Series A Stock"), the holders of the
Company's Series B Preferred Stock ("Series B Stock"), the holders of the
Company's Series C Preferred Stock ("Series C Stock"), the holders of the
Company's Series D-1 Preferred Stock ("Series D-1 Stock"), the holders of the
Company's Series E-1 Preferred Stock ("Series E-1 Stock") and the purchasers of
the Company's Series F Preferred Stock ("Series F Stock") set forth on EXHIBIT A
attached hereto (the "Purchasers"). The holders of the Series A Stock, Series B
Stock, Series C Stock and purchasers of Series F Stock shall be referred to
hereinafter as the "Financial Investors" and each individually as a "Financial
Investor." The holders of the Series D-1 Stock and the Series E-1 Stock shall be
referred to hereinafter as the "Strategic Investors" and each individually as a
"Strategic Investor." The Financial Investors and Strategic Investors
collectively shall be referred to hereinafter as the "Investors" and each
individually as an "Investor."
RECITALS
WHEREAS, the Company entered into the First Amended and Restated
Investors' Rights Agreement, dated March 31, 1997, with the holders of the
Company's Series A Stock, Series B Stock, Series C Stock, Series D-1 Stock and
Series E-1 Stock (the "First Amended and Restated Investors' Rights Agreement"),
whereby the Company granted to such holders certain registration rights,
information rights and other rights
WHEREAS, the Company proposes to sell and issue up to six million eight
hundred ten thousand seven hundred and ten (6,810,710) shares of its Series F
Stock to the Purchasers pursuant to the Series F Stock Purchase Agreement (the
"Purchase Agreement") of even date herewith;
WHEREAS, as a condition to the purchase of the Series F Stock, the
Purchasers have requested that the Company extend to them certain registration
rights, information rights and other rights; and
WHEREAS, the Company and the Investors desire to amend and restate the
First Amended and Restated Investors' Rights Agreement to provide for certain
registration rights, information rights and other rights to the Purchasers, as
set forth below.
NOW, THEREFORE, in consideration of the mutual promises,
representations, warranties, covenants and conditions set forth in this
Agreement, the parties mutually agree as follows:
1. GENERAL
1.1 DEFINITIONS. As used in this Agreement the following terms shall
have the following respective meanings:
"EXCHANGE ACT" means the Securities Exchange Act of 1934, as amended.
"FINANCIAL HOLDER" means any Financial Investor (or permitted successor
or assignee) owning of record Registrable Securities that have not been sold to
the public or any assignee of record of such Registrable Securities in
accordance with Section 3.11 hereof.
{PAGE}
"HOLDER" means either a Financial Holder or a Strategic Holder.
"INITIAL OFFERING" means the Company's first firm commitment
underwritten public offering of its Common Stock registered under the Securities
Act (as defined below).
"REGISTER," "REGISTERED," and "REGISTRATION" refer to a registration
effected by preparing and filing a registration statement in compliance with the
Securities Act, and the declaration or ordering of effectiveness of such
registration statement or document.
"REGISTRABLE SECURITIES" means (i) Common Stock of the Company issued
or issuable upon conversion of the Shares (as defined below); (ii) any Common
Stock of the Company issued as (or issuable upon the conversion or exercise of
any warrant, right or other security which is issued as) a dividend or other
distribution with respect to, or in exchange for or in replacement of, such
above-described securities and (iii) any other Common Stock now or hereafter
owned or held by any Investor. Notwithstanding the foregoing, Registrable
Securities shall not include any securities sold by a person to the public
either pursuant to a registration statement or Rule 144 or sold in a private
transaction in which the transferror's rights under Section 2 of this Agreement
are not assigned.
"REGISTRABLE SECURITIES THEN OUTSTANDING" shall be the number of shares
determined by calculating the total number of shares of the Company's Common
Stock that are Registrable Securities and either (1) are then issued and
outstanding or (2) are issuable pursuant to then exercisable or convertible
securities.
"REGISTRATION EXPENSES" shall mean all expenses incurred by the Company
in complying with Section 3.1, Section 3.2, Section 3.3, Section 3.4 and Section
3.5 hereof, including, without limitation, all registration and filing fees,
printing expenses, fees and disbursements of counsel for the Company, reasonable
fees and disbursements not to exceed for each registration effected pursuant to
this Agreement twenty thousand dollars ($20,000) of a single special counsel for
the Holders, blue sky fees and expenses and the expense of any special audits
incident to or required by any such registration (but excluding the compensation
of regular employees of the Company which shall be paid in any event by the
Company).
"SECURITIES ACT" shall mean the Securities Act of 1933, as amended.
"SELLING EXPENSES" shall mean all underwriting discounts and selling
commissions applicable to the sale.
"SHARES" shall mean the Company's Series A Stock, Series B Stock,
Series C Stock, including shares of Series C Stock issuable upon conversion of
warrants issued by the Company, Series D-1 Stock, Series D-2 Stock, Series E-1
Stock, Series E-2 Stock and Series F Stock.
"STRATEGIC HOLDER" means any Strategic Investor (or permitted successor
or assignee) owning of record Registrable Securities that have not been sold to
the public or any assignee of record of such Registrable Securities in
accordance with Section 3.11 hereof.
"FORM S-3" means such form under the Securities Act as in effect on the
date hereof or any successor registration form under the Securities Act
subsequently adopted by the SEC which permits
{PAGE}
inclusion or incorporation of substantial information by reference to other
documents filed by the Company with the SEC.
"SEC" or "COMMISSION" means the Securities and Exchange Commission.
1.2 The First Amended and Restated Investors' Rights Agreement shall be
terminated and replaced in its entirely by this Agreement.
2. RESTRICTION ON TRANSFER.
2.1 Each Holder agrees not to make any disposition of all or any
portion of the Shares or Registrable Securities unless and until:
(a) There is then in effect a registration statement under the
Securities Act covering such proposed disposition and such disposition is made
in accordance with such registration statement; or
(b) (i) The transferee has agreed in writing to be bound by
this Section 2, (ii) such Holder shall have notified the Company of the proposed
disposition and shall have furnished the Company with a detailed statement of
the circumstances surrounding the proposed disposition, and (iii) if reasonably
requested by the Company, such Holder shall have furnished the Company with an
opinion of counsel, reasonably satisfactory to the Company, that such
disposition will not require registration of such shares under the Securities
Act. It is agreed that the Company will not require opinions of counsel for
transactions made pursuant to Rule 144 except in unusual circumstances.
(c) Notwithstanding the provisions of paragraphs (a) and (b)
above, no such registration statement or opinion of counsel shall be necessary
for a transfer by a Holder which is (i) a partnership to its partners or former
partners in accordance with partnership interests, (ii) a corporation to its
shareholders in accordance with their interest in the corporation, (iii) a
limited liability company to its members or former members in accordance with
their interest in the limited liability company, or (iv) to the Holder's family
member or trust for the benefit of an individual Holder, provided the transferee
will be subject to the terms of this Section 2 to the same extent as if he were
an original Holder hereunder.
2.2 Each certificate representing Shares or Registrable Securities
shall (unless otherwise permitted by the provisions of the Agreement) be stamped
or otherwise imprinted with a legend substantially similar to the following (in
|
End of Preview |
Home Intelligence Services Subscriptions News About Us